Sapporo Clinical Laboratory Inc. (JASDAQ:9776) announces a share repurchase program. Under the program, the company will repurchase up to 53,700 shares, representing 1.58% of its issued share capital (excluding treasury stock), for a total purchase price of ¥69.11 million. The shares will be repurchased at a price of ¥1,287 per share.

The purpose of the program is to carry out agile capital policy in response to changes in the business environment. As of February 28, 2022, the company has 3,406,978 issued shares (excluding treasury stock) and 809,022 treasury shares.